None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Gender: Male or Female 18 to 50 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4) Are free of any systemic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to join the training program throughout the study duration.
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 4. Have participated in any interventional clinical trial in the previous 90 days. 5. Have a known sensitivity to any of the constituents of the test product including sensitivities to any ingredient 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Muscle ThicknessTimepoint: Day 0, Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Body FatTimepoint: Day 0, Day 28;Change in the weightTimepoint: Day 0, Day 28;Change in the Resting MetabolismTimepoint: Day 0, Day 28 | — |
Countries
India
Contacts
CCFT Laboratories